Literature DB >> 34432249

A High-Throughput Method to Prioritize PROTAC Intracellular Target Engagement and Cell Permeability Using NanoBRET.

James D Vasta1, Cesear R Corona2, Matthew B Robers2.   

Abstract

Target engagement and cell permeation are important parameters that may limit the efficacy of proteolysis-targeting chimeras (PROTACs). Here, we present an approach that facilitates both the quantitation of PROTAC binding affinity for an E3 ligase of interest, as well as the assessment of relative intracellular availability. We present a panel of E3 ligase target engagement assays based upon the NanoBRET Target Engagement platform. Querying E3 ligase engagement under live-cell and permeabilized-cell conditions allow calculation of an availability index that can be used to rank order the intracellular availability of PROTACs. Here we present examples where the cellular availability of PROTACs and their monovalent precursors are prioritized using NanoBRET assays for CRBN or VHL E3 ligases.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BRET; E3 Ligase; Heterobifunctional degrader; Intracellular Availability; Intracellular affinity; NanoBRET™; PROTAC; Permeability; Target engagement; Targeted protein degradation

Mesh:

Substances:

Year:  2021        PMID: 34432249     DOI: 10.1007/978-1-0716-1665-9_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.

Authors:  Kanak Raina; Jing Lu; Yimin Qian; Martha Altieri; Deborah Gordon; Ann Marie K Rossi; Jing Wang; Xin Chen; Hanqing Dong; Kam Siu; James D Winkler; Andrew P Crew; Craig M Crews; Kevin G Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

Review 2.  Monitoring and deciphering protein degradation pathways inside cells.

Authors:  Danette L Daniels; Kristin M Riching; Marjeta Urh
Journal:  Drug Discov Today Technol       Date:  2018-12-19

3.  Quantitative, Real-Time Measurements of Intracellular Target Engagement Using Energy Transfer.

Authors:  Matthew B Robers; James D Vasta; Cesear R Corona; Rachel Friedman Ohana; Robin Hurst; Manisha A Jhala; Kenneth M Comess; Keith V Wood
Journal:  Methods Mol Biol       Date:  2019

Review 4.  PROTACs: A novel strategy for cancer therapy.

Authors:  Jing Liu; Jia Ma; Yi Liu; Jun Xia; Yuyun Li; Z Peter Wang; Wenyi Wei
Journal:  Semin Cancer Biol       Date:  2020-02-11       Impact factor: 15.707

5.  Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition.

Authors:  Julianty Frost; Carles Galdeano; Pedro Soares; Morgan S Gadd; Katarzyna M Grzes; Lucy Ellis; Ola Epemolu; Satoko Shimamura; Marcus Bantscheff; Paola Grandi; Kevin D Read; Doreen A Cantrell; Sonia Rocha; Alessio Ciulli
Journal:  Nat Commun       Date:  2016-11-04       Impact factor: 14.919

6.  Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement.

Authors:  James D Vasta; Cesear R Corona; Jennifer Wilkinson; Chad A Zimprich; James R Hartnett; Morgan R Ingold; Kristopher Zimmerman; Thomas Machleidt; Thomas A Kirkland; Kristin G Huwiler; Rachel Friedman Ohana; Michael Slater; Paul Otto; Mei Cong; Carrow I Wells; Benedict-Tilman Berger; Thomas Hanke; Carina Glas; Ke Ding; David H Drewry; Kilian V M Huber; Timothy M Willson; Stefan Knapp; Susanne Müller; Poncho L Meisenheimer; Frank Fan; Keith V Wood; Matthew B Robers
Journal:  Cell Chem Biol       Date:  2017-11-22       Impact factor: 8.116

7.  Intracellular drug bioavailability: a new predictor of system dependent drug disposition.

Authors:  André Mateus; Andrea Treyer; Christine Wegler; Maria Karlgren; Pär Matsson; Per Artursson
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

8.  Target engagement and drug residence time can be observed in living cells with BRET.

Authors:  Matthew B Robers; Melanie L Dart; Carolyn C Woodroofe; Chad A Zimprich; Thomas A Kirkland; Thomas Machleidt; Kevin R Kupcho; Sergiy Levin; James R Hartnett; Kristopher Zimmerman; Andrew L Niles; Rachel Friedman Ohana; Danette L Daniels; Michael Slater; Monika G Wood; Mei Cong; Yi-Qiang Cheng; Keith V Wood
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

9.  Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).

Authors:  Pedro Soares; Morgan S Gadd; Julianty Frost; Carles Galdeano; Lucy Ellis; Ola Epemolu; Sonia Rocha; Kevin D Read; Alessio Ciulli
Journal:  J Med Chem       Date:  2017-09-18       Impact factor: 7.446

10.  Developing degraders: principles and perspectives on design and chemical space.

Authors:  Hannah J Maple; Nat Clayden; Anne Baron; Callum Stacey; Robert Felix
Journal:  Medchemcomm       Date:  2019-08-12       Impact factor: 3.597

View more
  3 in total

1.  Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation.

Authors:  Charles E Hendrick; Jeff R Jorgensen; Charu Chaudhry; Iulia I Strambeanu; Jean-Francois Brazeau; Jamie Schiffer; Zhicai Shi; Jennifer D Venable; Scott E Wolkenberg
Journal:  ACS Med Chem Lett       Date:  2022-06-20       Impact factor: 4.632

2.  Cereblon covalent modulation through structure-based design of histidine targeting chemical probes.

Authors:  Justin T Cruite; Geoffrey P Dann; Jianwei Che; Katherine A Donovan; Silas Ferrao; Scott B Ficarro; Eric S Fischer; Nathanael S Gray; Fidel Huerta; Nikki R Kong; Hu Liu; Jarrod A Marto; Rebecca J Metivier; Radosław P Nowak; Breanna L Zerfas; Lyn H Jones
Journal:  RSC Chem Biol       Date:  2022-07-08

3.  Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood-Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2.

Authors:  Xingui Liu; Alexia F Kalogeropulou; Sofia Domingos; Nikolai Makukhin; Raja S Nirujogi; Francois Singh; Natalia Shpiro; Anton Saalfrank; Esther Sammler; Ian G Ganley; Rui Moreira; Dario R Alessi; Alessio Ciulli
Journal:  J Am Chem Soc       Date:  2022-08-25       Impact factor: 16.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.